CAR T-cell-mediated delivery of bispecific innate immune cell engagers for neuroblastoma-Reference-Cited by-同舟云学术

CAR T-cell-mediated delivery of bispecific innate immune cell engagers for neuroblastoma

Published:2024-08-21 Issue:1 Volume:15 Page:
ISSN:2041-1723
Container-title:Nature Communications
language:en
Short-container-title:Nat Commun

Author:

Pascual-Pasto Guillem^ORCID,McIntyre Brendan^ORCID,Hines Margaret G.,Giudice Anna M.^ORCID,Garcia-Gerique Laura,Hoffmann Jennifer,Mishra Pamela,Matlaga Stephanie,Lombardi Simona,Shraim Rawan,Schürch Patrick M.,Yarmarkovich Mark,Hofmann Ted J.,Alikarami Fatemeh,Martinez Daniel,Tsang Matthew,Gil-de-Gómez Luis,Spear Timothy T.,Bernt Kathrin M.^ORCID,Wolpaw Adam J.^ORCID,Dimitrov Dimiter S.^ORCID,Li Wei,Bosse Kristopher R.^ORCID

Funder

Damon Runyon Cancer Research Foundation

EIF | Stand Up To Cancer

Alex's Lemonade Stand Foundation for Childhood Cancer

U.S. Department of Health & Human Services | NIH | National Cancer Institute

Solving Kids' Cancer

Publisher

Springer Science and Business Media LLC

Link

https://www.nature.com/articles/s41467-024-51337-2.pdf

Reference85 articles.

1. June, C. H. & Sadelain, M. Chimeric antigen receptor therapy. N. Engl. J. Med 379, 64–73 (2018).

2. Maude, S. L. et al. Tisagenlecleucel in children and young adults with b-cell lymphoblastic leukemia. N. Engl. J. Med 378, 439–448 (2018).

3. Hou, A. J., Chen, L. C. & Chen, Y. Y. Navigating CAR-T cells through the solid-tumour microenvironment. Nat. Rev. Drug Discov. 20, 531–550 (2021).

4. Majzner, R. G. et al. Tuning the antigen density requirement for CAR T-cell activity. Cancer Discov. 10, 702–723 (2020).

5. Hirabayashi, K. et al. Dual targeting car-t cells with optimal costimulation and metabolic fitness enhance antitumor activity and prevent escape in solid tumors. Nat. Cancer 2, 904–918 (2021).